Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA)

L. C. Rall, N. T. Lundgren, S. Reichlin, Johannes D Veldhuis, J. J. Kehayias, R. Roubenoff

Research output: Contribution to journalArticle

Abstract

We have previously demonstrated alterations in GH kinetics and a reduction in body cell mass (BCM) among patients with RA compared to healthy young and elderly individuals. However, because GH production declines with age, it remains unclear whether the alteration in GH is primarily an age- or disease-related phenomenon. Therefore, we examined 24-hr GH kinetics among 12 patients with RA and 25 healthy individuals of the same age range (22-65 yr). 24-hr GH kinetics were determined by deconvolution analysis. After controlling for age and BCM, 24-hr mean and integrated GH levels were lower among RA compared to healthy subjects (0.86 ± 0.45 vs. 1.19 ± 0.96 ng/ml, and 1228.2 ± 638.2 vs. 1685.7 ± 1423.5 ng, respectively, p < 0.05). There was a trend toward lower GH production rates in the RA vs. healthy subjects (44.6 ± 25.5 vs. 51.3 ± 41.3 ng/ml/d, respectively, p = 0.08). These findings suggest that: 1) reduced circulating GH occurs in RA compared to nealthy individuals of similar age and body composition, and 2) decreased GH production rates may contribute to reduced circulating GH levels in RA.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997
Externally publishedYes

Fingerprint

rheumatoid arthritis
somatotropin
Growth Hormone
Rheumatoid Arthritis
kinetics
Kinetics
Healthy Volunteers
Deconvolution
Body Composition
body composition
cells

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Rall, L. C., Lundgren, N. T., Reichlin, S., Veldhuis, J. D., Kehayias, J. J., & Roubenoff, R. (1997). Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA). FASEB Journal, 11(3).

Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA). / Rall, L. C.; Lundgren, N. T.; Reichlin, S.; Veldhuis, Johannes D; Kehayias, J. J.; Roubenoff, R.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

Rall, LC, Lundgren, NT, Reichlin, S, Veldhuis, JD, Kehayias, JJ & Roubenoff, R 1997, 'Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA)', FASEB Journal, vol. 11, no. 3.
Rall LC, Lundgren NT, Reichlin S, Veldhuis JD, Kehayias JJ, Roubenoff R. Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA). FASEB Journal. 1997;11(3).
Rall, L. C. ; Lundgren, N. T. ; Reichlin, S. ; Veldhuis, Johannes D ; Kehayias, J. J. ; Roubenoff, R. / Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA). In: FASEB Journal. 1997 ; Vol. 11, No. 3.
@article{3446c40100ab4b24b7456c2e32a4f3f7,
title = "Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA)",
abstract = "We have previously demonstrated alterations in GH kinetics and a reduction in body cell mass (BCM) among patients with RA compared to healthy young and elderly individuals. However, because GH production declines with age, it remains unclear whether the alteration in GH is primarily an age- or disease-related phenomenon. Therefore, we examined 24-hr GH kinetics among 12 patients with RA and 25 healthy individuals of the same age range (22-65 yr). 24-hr GH kinetics were determined by deconvolution analysis. After controlling for age and BCM, 24-hr mean and integrated GH levels were lower among RA compared to healthy subjects (0.86 ± 0.45 vs. 1.19 ± 0.96 ng/ml, and 1228.2 ± 638.2 vs. 1685.7 ± 1423.5 ng, respectively, p < 0.05). There was a trend toward lower GH production rates in the RA vs. healthy subjects (44.6 ± 25.5 vs. 51.3 ± 41.3 ng/ml/d, respectively, p = 0.08). These findings suggest that: 1) reduced circulating GH occurs in RA compared to nealthy individuals of similar age and body composition, and 2) decreased GH production rates may contribute to reduced circulating GH levels in RA.",
author = "Rall, {L. C.} and Lundgren, {N. T.} and S. Reichlin and Veldhuis, {Johannes D} and Kehayias, {J. J.} and R. Roubenoff",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Altered growth hormone (GH) kinetics in rheumatoid arthritis (RA)

AU - Rall, L. C.

AU - Lundgren, N. T.

AU - Reichlin, S.

AU - Veldhuis, Johannes D

AU - Kehayias, J. J.

AU - Roubenoff, R.

PY - 1997

Y1 - 1997

N2 - We have previously demonstrated alterations in GH kinetics and a reduction in body cell mass (BCM) among patients with RA compared to healthy young and elderly individuals. However, because GH production declines with age, it remains unclear whether the alteration in GH is primarily an age- or disease-related phenomenon. Therefore, we examined 24-hr GH kinetics among 12 patients with RA and 25 healthy individuals of the same age range (22-65 yr). 24-hr GH kinetics were determined by deconvolution analysis. After controlling for age and BCM, 24-hr mean and integrated GH levels were lower among RA compared to healthy subjects (0.86 ± 0.45 vs. 1.19 ± 0.96 ng/ml, and 1228.2 ± 638.2 vs. 1685.7 ± 1423.5 ng, respectively, p < 0.05). There was a trend toward lower GH production rates in the RA vs. healthy subjects (44.6 ± 25.5 vs. 51.3 ± 41.3 ng/ml/d, respectively, p = 0.08). These findings suggest that: 1) reduced circulating GH occurs in RA compared to nealthy individuals of similar age and body composition, and 2) decreased GH production rates may contribute to reduced circulating GH levels in RA.

AB - We have previously demonstrated alterations in GH kinetics and a reduction in body cell mass (BCM) among patients with RA compared to healthy young and elderly individuals. However, because GH production declines with age, it remains unclear whether the alteration in GH is primarily an age- or disease-related phenomenon. Therefore, we examined 24-hr GH kinetics among 12 patients with RA and 25 healthy individuals of the same age range (22-65 yr). 24-hr GH kinetics were determined by deconvolution analysis. After controlling for age and BCM, 24-hr mean and integrated GH levels were lower among RA compared to healthy subjects (0.86 ± 0.45 vs. 1.19 ± 0.96 ng/ml, and 1228.2 ± 638.2 vs. 1685.7 ± 1423.5 ng, respectively, p < 0.05). There was a trend toward lower GH production rates in the RA vs. healthy subjects (44.6 ± 25.5 vs. 51.3 ± 41.3 ng/ml/d, respectively, p = 0.08). These findings suggest that: 1) reduced circulating GH occurs in RA compared to nealthy individuals of similar age and body composition, and 2) decreased GH production rates may contribute to reduced circulating GH levels in RA.

UR - http://www.scopus.com/inward/record.url?scp=33750153262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750153262&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750153262

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -